Badreddin Edris is COO at SpringWorks Therapeutics, Inc. (SWTX). They have made 3 open-market trades across 2 companies since 2021, most recently 2026-01-21.
CIK 0001786966
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SWTX | 169,712 | $8.0M |
| EWTX | 127,686 | $4.8M |
| Total | $12.7M |
Shares reported on the most recent Form 4, priced at the 2026-01-23 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EWTX | SELL | 2026-01-21 | 2026-01-23 | $29.44 | $3.4M | +0.5% | +6.2% | +10.2% |
| SWTX | SELL · 10b5-1 | 2025-03-03 | 2025-03-05 | $54.21 | $2.1M | -3.3% | -24.2% | -9.3% |
| SWTX | SELL · 10b5-1 | 2025-02-10 | 2025-02-12 | $53.13 | $1.6M | -7.4% | -12.4% | -20.8% |
| SWTX | SELL · 10b5-1 | 2024-12-03 | 2024-12-05 | $41.96 | $1.7M | -9.7% | -6.9% | +21.2% |
| SWTX | SELL · 10b5-1 | 2024-09-03 | 2024-09-04 | $40.88 | $1.1M | -13.4% | -20.5% | +3.6% |
| SWTX | SELL · 10b5-1 | 2024-06-03 | 2024-06-05 | $40.05 | $1.6M | -9.5% | -9.2% | -0.2% |
| SWTX | SELL | 2021-07-01 | 2021-07-01 | $85.35 | $2.7M | -8.1% | -0.7% | -27.0% |
| SWTX | SELL | 2021-01-25 | 2021-01-26 | $84.07 | $2.7M | +10.2% | +10.3% | -8.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.